SEC Form 4 · accession 0000899243-18-029784
X4 Pharmaceuticals, Inc · XFOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gray
Officer — President, CEO and CFO · Director
Period of report
Nov 27, 2018
Accepted (ET)
Nov 28, 2018 · 9:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501697
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2018 | A | 250,000 | $0.00 | A | 250,000 | D |
Table II — derivative securities
No Table II lines on this filing.